{
    "2018-05-11": [
        [
            {
                "time": "2018-04-15",
                "original_text": "An Ear To The Pharma: 8 Stocks To Watch (VYGR, BOLD, RXII, CYADâ€¦)",
                "features": {
                    "keywords": [
                        "Pharma",
                        "Stocks",
                        "Watch"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-20",
                "original_text": "Trump Announces Plan to Reign In Drug Prices and Pharma Stocks Rally.",
                "features": {
                    "keywords": [
                        "Trump",
                        "Drug Prices",
                        "Pharma Stocks",
                        "Rally"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-09",
                "original_text": "[$$] Eli Lilly Buys Immunotherapy Cancer Treatment Company for $1.6 Billion",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Immunotherapy",
                        "Cancer",
                        "Acquisition"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "cancer treatment"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-05-10",
                "original_text": "Lilly to Participate in UBS Global Healthcare Conference",
                "features": {
                    "keywords": [
                        "Lilly",
                        "UBS",
                        "Healthcare Conference"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-05-03",
                "original_text": "Radius Health (RDUS) Incurs Narrower-Than-Expected Q1 Loss",
                "features": {
                    "keywords": [
                        "Radius Health",
                        "Q1 Loss",
                        "Narrower-Than-Expected"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-05-02",
                "original_text": "Celldex (CLDX) Q1 Loss Wider Than Expected, Shares Down",
                "features": {
                    "keywords": [
                        "Celldex",
                        "Q1 Loss",
                        "Wider Than Expected",
                        "Shares Down"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-04-12",
                "original_text": "Pharma Stock Roundup: LLY to Buy Cancer Biotech, J&J, AZN, Roche Announce Updates",
                "features": {
                    "keywords": [
                        "LLY",
                        "Cancer Biotech",
                        "J&J",
                        "AZN",
                        "Roche",
                        "Updates"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals",
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-05-08",
                "original_text": "How Teva Performed in 1Q18",
                "features": {
                    "keywords": [
                        "Teva",
                        "1Q18",
                        "Performance"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-04-25",
                "original_text": "Label Expansion May Boost Keytruda’s Revenue Prospects in 2018",
                "features": {
                    "keywords": [
                        "Label Expansion",
                        "Keytruda",
                        "Revenue Prospects",
                        "2018"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "oncology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-28",
                "original_text": "Keytruda Continues to Be Major Growth Driver for Merck in 2018",
                "features": {
                    "keywords": [
                        "Keytruda",
                        "Growth Driver",
                        "Merck",
                        "2018"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "oncology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}